EDITOR-IN-CHIEF
Professor,Department of Education
GC University Faisalabad
Pakistan.
Email: khudabakhsh@gcuf.edu.pk
editorinchiefijmasri@gmail.com
Publisher
KRISHMA PUBLICATION (Reg 17/2020)
2 /57 A,
Middle street, Pali, Pali, Viluppuram,
Ulundurpettai, Tamil Nadu,
606104
Email: krishmapublication@gmail.com
UNFAVORABLE EFFECTS OF PEG- IFN (INTERPHERON) ALPHA+ RIBAVIRINB DEVELOPED IN 24 WEEKS OF TREATMENT BESIDE HEPATITIS C
Almost 5.3% people are being ill with (hepatitis C virus HCV) in Pakistan. The therapy allotted to most
of genotypes is a mixture of interferon and ribavirin. The patients received some side effects. The study was
consisted of 25 people. Peg-Interferon alpha+ Ribavirinb
treatment was prescribed for constant hepatitis C from
September 2015 to February 2016 for 24 weeks. Those patients noted down in our questionnaire and updated us
about side effects which they had faced during the whole period. Overall, side effects were fatigue, nausea,
anemia, rashes, decreased appetite, chills, influenza like symptoms, neutropenia and hair loss. Most common
side effect was hair loss (87%). It is concluded that combined therapy of peg-Interferon alpha+ Ribavirinb
also
have side effects. Further approaches with fewer side effects are needed for the treatment of hepatitis C.
- 2021-05-09 10:06:18 Subject Area - Biochemistry
Announcement
Subject Area
Agricultural Sciences
- Agricultural microbiology
- Agricultural extension
- Agricultural biotechnology
- plant technology
- environmental science
- plant and biotechnology
- More→
Life Sciences
- General Microbiology
- Botany
- Zoology
- bio technology
- medical microbiology
- More→
Social Science and Humanities
- Economics
- Education
- English
- Literature
- women studies
- Entrepreneurship
- More→
Health Science
- Medical
- Dental sciences
- Physiotherapy
- Nursing care
- Biotechnology
- Pharmacy
- More→
Physical Sciences and Engineering
- Electrical Engineering
- Electronics & Communication
Engineering - Graphics and Multimedia
- Software Engineering
- Biological Engineering
- More→